Agilent Technologies and Integrated DNA Technologies Provide a New Solution for qPCR Studies 15 Jun 2010: Agilent Technologies Inc. and Integrated DNA Technologies (IDT) have partnered to provide a complete solution for qPCR studies. The combination of the Mx3005P qPCR system and Brilliant qPCR reagents from Agilent with PrimeTime qPCR Assays from IDT provides customers a fully supported solution that is ideal for qPCR studies. Agilent Technologies
|
Society for Biomolecular Sciences Announces Call for Papers 14 Jun 2010: The Society for Biomolecular Sciences (SBS) announced today that they are accepting abstracts for the SBS 17th Annual Conference and Exhibition, Advancing the Science of Drug Discovery, which will take place March 27- 31, 2011 at the Gaylord Palms Resort and Convention Center in Orlando, Florida. Society for Biomolecular Sciences (SBS)
|
Lonza Introduces Clonetics® Human Retinal Pigment Epithelial Cells & RtEGM™ Growth Medium 14 Jun 2010: Lonza is pleased to announce the availability of cryopreserved Clonetics® Human Retinal Pigment Epithelial (hRPE) Cells and optimized RtEGM™ Growth Medium BulletKit® for ophthalmologic research including age-related macular degeneration, retinistis pigmentosa, and gene expression profiles of RPE. Lonza Group Ltd
|
UVP Announces Major Software Upgrade for VisionWorksLS Analysis Software
14 Jun 2010: UVP, LLC announces a major upgrade to the VisionWorks®LS Software, configured with UVP’s BioImaging Systems, making this version the most streamlined, efficient design for personalized workflow. The new VisionWorksLS 7.0 software includes a redesigned interface, portable analysis data, capture templates and compatibility with Windows 7. UVP, LLC.
|
DNASTAR Software Grant Supports Ion Torrent Awards 11 Jun 2010: DNASTAR® announced today that it will join Ion Torrent in supporting the Ion PGM Sequencer Grant Program by providing perpetual licenses of its next-gen sequencing suite of software tools to the two European winners of the recently announced extension of the grant program. DNASTAR Inc.
|
InVitria Announces New Product, ITSE Animal-Free for Cell Culture Scientists
10 Jun 2010: InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. InVitria
|
Accuri and eBioscience - Two Leading Suppliers Team Up 10 Jun 2010: Accuri is pleased to announce a co-marketing agreement with eBioscience. The collaboration is designed to offer scientists a better, and more comprehensive, solution for their flow cytometry research needs in the US and Europe. The agreement pairs the cost-effectiveness, ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with the market-leading line of over 11,000 cell analysis reagents offered by eBioscience. Accuri Cytometers, Inc.
|
Fluidigm Introduces World's First Reusable Biochip Architecture
09 Jun 2010: Fluidigm Corporation has announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates. Fluidigm Corporation
|
Stem Cell-Derived Human Neurons in CNS Drug Discovery 07 Jun 2010: In this application note from Molecular Devices reproducible batches of human neurons are generated that will significantly improve and impact CNS drug discovery. The stem cell-derived neurons express all known markers typically associated with mature neurons and are functionally active. These neurons have been used in a recent screen to identify antagonists of a novel GPCR target implicated in schizophrenia. Molecular Devices
|
New Tools to Study Genomic Instability
03 Jun 2010: AMSBIO announces a new second generation PARP in vivo Pharmacodynamic Assay that accurately measures net poly (ADP-ribose) (PAR) levels in cellular extracts and has been used to document differences in PAR levels in human tumour lysates from a variety of tissues, organs and xenografts. AMSBIO
|